Wall Street analysts predict that Artivion, Inc. (NYSE:AORT – Get Rating) will announce $73.55 million in sales for the current quarter, Zacks reports. Two analysts have made estimates for Artivion’s earnings. The highest sales estimate is $74.60 million and the lowest is $72.50 million. Artivion reported sales of $71.09 million in the same quarter last […]
/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate.
Brokerages expect Artivion, Inc. (NYSE:AORT – Get Rating) to report earnings per share (EPS) of ($0.04) for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Artivion’s earnings. The lowest EPS estimate is ($0.18) and the highest is $0.05. Artivion reported earnings per share of ($0.08) in the same quarter last […]
/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today published its inaugural Corporate.
/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will host an.